Author: Brittney Wheeler

Researchers at Washington University School of Medicine and Saint Louis University found that less than half of Americans who received treatment for opioid use disorder over a five-year period were offered a potentially lifesaving medication.

Alivia Kaplan founded Kuleana Consulting, a global consulting company that connects students with businesses across the globe. She is set to earn a bachelor’s degree in economics and strategy from Olin Business School on May 20.

Camillo Padoa-Schioppa, professor at the School of Medicine, received a five-year $2.3 million grant from the National Institutes of Health (NIH) for research titled “Neuronal mechanisms of good-based economic decisions.”

Vijay K. Samineni, assistant professor of anesthesiology at the School of Medicine, received a five-year $2.3 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH).

Three science writers in Medical Public Affairs at the School of Medicine were honored by the Association of American Medical Colleges (AAMC) for writing excellence at the organization’s recent Group on Institutional Advancement’s annual meeting.

Daniel E. Goldberg, MD, PhD, a renowned researcher in molecular parasitology at Washington University School of Medicine, has been elected to the National Academy of Sciences.

Recognition Days will honor university staff members, 2022 service award recipients and Distinguished Honor Award winners beginning May 23.

A new grant awarded to School of Medicine researchers will fund research investigating the role of the immune system in heart failure. Finding ways to harness beneficial immune cells could lead to new therapies that encourage the heart to heal after injuries.

The American Diabetes Association announced that Janet B. McGill, MD, a professor of medicine at Washington University School of Medicine, will receive the organization’s 2022 Outstanding Physician Clinician in Diabetes Award.

A study by researchers at Washington University School of Medicine in St. Louis and the Broad Institute of MIT and Harvard suggests that women who get recurrent urinary tract infections may be caught in a vicious cycle in which antibiotics given to eradicate one infection predispose them to develop another.